Investors

People are different and so is their cancer, patients should be treated individually.

Latest News

IGNITE update – Eight hospitals have been enrolled in the program

Read more

Directed Issue 2020

Directed Issue 2020

Company presentation

Please click here to download our Company presentation

Structure of Directed Issue including warrants to current shareholders

Please click here to download structure of Directed Issue and warrants

Upcoming events

May 24, 2022

Interim Report Q1 2022 released

View previous reports

May 24, 2022

Annual General Meeting

Watch past presentations

August 25, 2022

Interim Report Q2 2022 released

View previous reports

November 24, 2022

Interim Report Q3 2022 released

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.

Read more